|Correlation of circular RNA abundance with proliferation–exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues|
A Bachmayr-Heyda, AT Reiner, K Auer, N Sukhbaatar, S Aust, ...
Scientific reports 5 (1), 1-10, 2015
|In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.|
S Bautista, H Valles, RL Walker, S Anzick, R Zeillinger, P Meltzer, ...
Clinical Cancer Research 4 (12), 2925-2929, 1998
|Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups|
F Courjal, M Cuny, J Simony-Lafontaine, G Louason, P Speiser, ...
Cancer research 57 (19), 4360-4367, 1997
|Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain.|
C Schneeberger, P Speiser, F Kury, R Zeillinger
Genome Research 4 (4), 234-238, 1995
|Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients|
R Königsberg, E Obermayr, G Bises, G Pfeiler, M Gneist, F Wrba, ...
Acta oncologica 50 (5), 700-710, 2011
|Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors|
F Courjal, G Louason, P Speiser, D Katsaros, R Zeillinger, C Theillet
International journal of cancer 69 (4), 247-253, 1996
|Transdominant ΔTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo|
N Concin, K Becker, N Slade, S Erster, E Mueller-Holzner, H Ulmer, ...
Cancer Research 64 (7), 2449-2460, 2004
|Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease‐free survival|
A Obermair, E Kucera, K Mayerhofer, P Speiser, M Seifert, K Czerwenka, ...
International journal of cancer 74 (4), 455-458, 1997
|Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer|
LA Hefler, N Concin, G Hofstetter, C Marth, A Mustea, J Sehouli, ...
Clinical cancer research 14 (3), 710-714, 2008
|Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer|
LA Hefler, R Zeillinger, C Grimm, AK Sood, WF Cheng, A Gadducci, ...
Gynecologic oncology 103 (2), 512-517, 2006
|Contribution of epigenetic silencing of tumor necrosis factor–related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer|
P Horak, D Pils, G Haller, I Pribill, M Roessler, S Tomek, R Horvat, ...
Molecular cancer research 3 (6), 335-343, 2005
|MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+ CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition|
D Chen, Y Zhang, J Wang, J Chen, C Yang, K Cai, X Wang, F Shi, J Dou
Journal of ovarian research 6 (1), 1-11, 2013
|Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer|
A Kafka, G Sauer, C Jaeger, R Grundmann, R Kreienberg, R Zeillinger, ...
International journal of oncology 22 (5), 1117-1121, 2003
|The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells|
BC Schmid, GA Rezniczek, G Fabjani, T Yoneda, S Leodolter, R Zeillinger
Breast cancer research and treatment 106 (3), 333-342, 2007
|Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer|
LA Hefler, A Mustea, D Könsgen, N Concin, B Tanner, R Strick, G Heinze, ...
Clinical Cancer Research 13 (3), 898-901, 2007
|Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women|
LA Hefler, C Grimm, T Lantzsch, D Lampe, S Leodolter, H Koelbl, ...
Clinical cancer research 11 (16), 5718-5721, 2005
|CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia|
BC Schmid, M Rudas, GA Rezniczek, S Leodolter, R Zeillinger
Breast cancer research and treatment 84 (3), 247-250, 2004
|Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer|
M Stimpfl, D Tong, B Fasching, E Schuster, A Obermair, S Leodolter, ...
Clinical cancer research 8 (7), 2253-2259, 2002
|Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients|
E Obermayr, F Sanchez-Cabo, MKM Tea, CF Singer, M Krainer, ...
BMC cancer 10 (1), 666, 2010
|Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage|
C Tempfer, G Unfried, R Zeillinger, L Hefler, F Nagele, JC Huber
Human reproduction 16 (8), 1644-1647, 2001